Navigation Links
Ibuprofen destroys aspirin's positive effect on stroke risk
Date:3/12/2008

BUFFALO, N.Y. -- Stroke patients who use ibuprofen for arthritis pain or other conditions while taking aspirin to reduce the risk of a second stroke undermine aspirins ability to act as an anti-platelet agent, researchers at the University at Buffalo have shown.

In a cohort of patients seen by physicians at two offices of the Dent Neurologic Institute, 28 patients were identified as taking both aspirin and ibuprofen (a nonsteroidal anti-inflammatory drug, or NSAID) daily and all were found to have no anti-platelet effect from their daily aspirin.

Thirteen of these patients were being seen because they had a second stroke/TIA while taking aspirin and a NSAID, and were platelet non-responsive to aspirin (aspirin resistant) at the time of that stroke.

The researchers found that when 18 of the 28 patients returned for a second neurological visit after discontinuing NSAID use and were tested again, all had regained their aspirin sensitivity and its ability to prevent blood platelets from aggregating and blocking arteries.

The study is the first to show the clinical consequences of the aspirin/NSAID interaction in patients being treated for prevention of a second stroke, and presents a possible explanation of the mechanism of action.

The Food and Drug Administration currently warns that ibuprofen might make aspirin less effective, but states that the clinical implications of the interaction have not been evaluated.

This interaction between aspirin and ibuprofen or prescription NSAIDs is one of the best-known, but well-kept secrets in stroke medicine, said Francis M. Gengo, Pharm.D., lead researcher on the study.

Its unfortunate that clinicians and patients often are unaware of this interaction. Whatever number of patients who have had strokes because of the interaction between aspirin and NSAIDs, those strokes were preventable.

Gengo is professor of neurology in the UB School of Medicine
'/>"/>

Contact: Lois Baker
ljbaker@buffalo.edu
716-645-5000 x1417
University at Buffalo
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related medicine news :

1. Ibuprofen Preserves Lung Function in Kids With Cystic Fibrosis
2. Ibuprofen associated with slower lung function decline in children with cystic fibrosis
3. Albemarle to Increase Price of Ibuprofen
4. Ibuprofen can slow lung disease in children with cystic fibrosis, Canadian study shows
5. Researchers train the immune system to deliver virus that destroys cancer in lab models
6. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
7. Positive results from phase 1 clinical trials of cuprindro
8. Single reader with CAD more efficient, yields fewer false positives, and possibly more sensitive
9. HPV-positive head and neck cancer patients fare better than HPV-negative patients
10. HPV-Positive Head and Neck Cancers Fare Better
11. Labopharm Reports Positive Results for Phase III Study on Once-daily Trazodone
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2
... good reason to consider taking finasteride, a wel...tate and reduces the risk of getting prostate canc...ncology Group strongly suggests that for men at ri...they are most easily treatable. , It appears that...
...Risks in 236 Countries and Territories and ...on-Specific Disease Information & Vital Profiles o...he World, BALTIMORE, Sept. 11 Combining their re...health,information website ever developed for inte...
...,Imaging Ltd. (Nasdaq: EMITF ) ("EMI") announced ...e "Offering Prospectus") in Israel for the offerin...egate principal amount of,NIS 440 million. These ...provides that the maximum interest rate of the Ser...
...he most on health care when compared to other Orga...(OECD) countries. Health care prices and higher pe... spending, according to a study by researchers at ...r health resourcesphysicians, nurses and hospital ...
...ices,International Inc. (Pink Sheets: MSITF) wishe...ts VScan HIV test kit and the VScan Hepatitis C,te...allow it to apply for,EU approval of both test kit...,when EU approval is received that it will result ...
...cancer is the,second leading cause of cancer death...mately 40,460 women in the U.S. will die from the ...sed with invasive breast cancer die,from the disea...rican,American women, has teamed up with Diahann C...
Other Medicine News:Health News:Generic prostate drug helps find high-risk cancers early 2Health News:Generic prostate drug helps find high-risk cancers early 3Health News:MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers 2Health News:MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers 3Health News:Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel 2Health News:Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel 3Health News:Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel 4Health News:United States continues to have highest level of health spending 2Health News:Medical Services International Inc. Completes Testing for European Union (EU) Application 2Health News:Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer 2
(Date:12/4/2009)MORRISTOWN, N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed
(Date:12/4/2009)WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: AZN ) today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tab
(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3CSC to Help Georgia Hospital Association Members Achieve Meaningful Use of Electronic Health Records 53827 1CSC to Help Georgia Hospital Association Members Achieve Meaningful Use of Electronic Health Records 53827 2AEterna Zentaris to Present at Upcoming Canaccord Adams 29th Annual Global Growth Conference 13410 1Micromet Inc Reports Second Quarter 2009 Financial Results 53819 1Micromet Inc Reports Second Quarter 2009 Financial Results 53819 2Micromet Inc Reports Second Quarter 2009 Financial Results 53819 3Micromet Inc Reports Second Quarter 2009 Financial Results 53819 4Micromet Inc Reports Second Quarter 2009 Financial Results 53819 5Micromet Inc Reports Second Quarter 2009 Financial Results 53819 6Micromet Inc Reports Second Quarter 2009 Financial Results 53819 7Micromet Inc Reports Second Quarter 2009 Financial Results 53819 8Micromet Inc Reports Second Quarter 2009 Financial Results 53819 9Micromet Inc Reports Second Quarter 2009 Financial Results 53819 10Micromet Inc Reports Second Quarter 2009 Financial Results 53819 11
Ministim® MS-1B Miniature Nerve Stimulator
...ntrol allows hands-free operation in nerve locator...SoloStim provides a wide range when distant from n...ported by Life-Techs complete selection of periphe... proven ProBloc™ single injection needles an...
...u deliver unmatched performance through patient-fo...complete anesthesia solution developed, putting pa...fingertips., ,The Aisys Carestation is built on o...sia delivery and patient monitoring technology. We...
...ght polypropylene mesh which offers an excellent b...ced considerably. Optilene Mesh LP is the alternat...ocedures. It perfectly conforms,to anatomical st...e Mesh LP adapts to the movements of the patient r...
Medicine Products: